Daclizumab – Manipulating the immune system in unexpected ways
Daclizumab, marketed as Zinbryta, was approved for the treatment of relapsing-remitting multiple sclerosis (MS) in the USA and Europe in summer 2016. Daclizumab has shown […]
iCancer – The first step into the future of funding clinical trials?
After I tweeted about my recent post about Immunium, another Twitter user made me aware of iCancer. Why? – Because […]
Immunicum – Scalable Personalised Cancer Immunotherapy
I thought I kick off the year with an article about Immunicum, a Swedish company I stumbled across a week […]